[Methicillin-resistant Staphylococcus aureus: evolution and epidemiology, clinical impact, and prevention]

C Brun-Buisson1

  • 1Service de Réanimation Médicale et Unité d'Hygiène et Prévention de l'Infection, CHU Henri Mondor, Créteil, France.

Pathologie-Biologie
|October 14, 1998
PubMed

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) is a growing hospital concern. Addressing reservoirs, patient transfers, and extended-care facilities is crucial for controlling MRSA spread.

Area of Science:

  • Infectious Diseases
  • Hospital Epidemiology
  • Antimicrobial Resistance

Context:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is endemic in many hospitals globally.
  • High endemicity presents challenges in reservoir identification, patient transfer notification, and controlling resistant bacteria in extended-care facilities.
  • Environmental contamination is a factor, but colonized or infected patients are the primary reservoir.

Purpose:

  • To identify significant challenges in managing endemic Methicillin-resistant Staphylococcus aureus (MRSA) in healthcare settings.
  • To explore technical responses for controlling MRSA dissemination, particularly during patient transfers.
  • To emphasize the need for a comprehensive, hospital-wide commitment to reducing MRSA endemicity.

Summary:

  • Key problems in high-MRSA endemicity include identifying reservoirs (especially healthy carriers), notifying receiving departments of transferred carriers, and managing resistant bacteria in extended-care facilities.
  • Technical solutions involve carrier detection in high-risk units, standardized transfer reporting, and electronic health record integration.
  • Carrier decontamination can be effective in specific scenarios to prevent cross-contamination.

Impact:

  • Effective management strategies are vital to mitigate the risk of resistant strain dissemination during inter-hospital patient transfers.
  • A unified commitment from all healthcare stakeholders is essential for successful MRSA endemicity reduction.
  • Implementing targeted interventions can help control the spread of MRSA within and between healthcare facilities.

Related Concept Videos

Mismatch Repair01:36

Mismatch Repair

Overview
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...